Imbalance between MMP-2, 9 and TIMP-1 promote the invasion and metastasis of renal cell carcinoma via SKP2 signaling pathways

[1]  A. di Carlo.  Matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in sera and urine of patients with renal carcinoma , 2013, Oncology letters.

[2]  Hongsheng Lu,et al.  The expression and clinical significance of matrix metalloproteinase 7 and tissue inhibitor of matrix metalloproteinases 2 in clear cell renal cell carcinoma , 2012, Experimental and therapeutic medicine.

[3]  Lianfeng Zhang,et al.  Downregulation of Skp2 inhibits the growth and metastasis of gastric cancer cells in vitro and in vivo , 2013, Tumor Biology.

[4]  R. Samaka,et al.  The Prognostic Value of Skp2 Expression in Egyptian Diffuse Large B-Cell Lymphoma , 2012, Applied immunohistochemistry & molecular morphology : AIMM.

[5]  C. Moore,et al.  An alternate perspective on the roles of TIMPs and MMPs in pathology. , 2012, The American journal of pathology.

[6]  W. Hung,et al.  Skp2 overexpression increases the expression of MMP-2 and MMP-9 and invasion of lung cancer cells. , 2010, Cancer letters.

[7]  S. Mobashery,et al.  Mechanism-based profiling of MMPs. , 2010, Methods in molecular biology.

[8]  T. Tachikawa,et al.  Expression of matrix metalloproteinases MMP‐2, MMP‐9 and their tissue inhibitors TIMP‐1 and TIMP‐2 in the epithelium and stroma of salivary gland pleomorphic adenomas , 2009, Histopathology.

[9]  Q. Fu,et al.  Prognostic implication of p27Kip1, Skp2 and Cks1 expression in renal cell carcinoma: a tissue microarray study , 2008, Journal of experimental & clinical cancer research : CR.

[10]  H. Nagase,et al.  Progress in matrix metalloproteinase research. , 2008, Molecular aspects of medicine.

[11]  I. Roninson,et al.  Regulation of Sp1 by cell cycle related proteins , 2008, Cell cycle.

[12]  K. Jung,et al.  Plasma matrix metalloproteinase‐7 as a metastatic marker and survival predictor in patients with renal cell carcinomas , 2008, Cancer science.

[13]  K. Mertz,et al.  pVHL co‐ordinately regulates CXCR4/CXCL12 and MMP2/MMP9 expression in human clear‐cell renal cell carcinoma , 2007, The Journal of pathology.

[14]  P. Rehak,et al.  Biological significance of p27 and Skp2 expression in renal cell carcinoma. A systematic analysis of primary and metastatic tumour tissues using a tissue microarray technique , 2004, Virchows Archiv.

[15]  Yasuo Watanabe,et al.  S-phase kinase-associated protein 2 expression in laryngeal squamous cell carcinomas and its prognostic implications. , 2003, Oncology reports.

[16]  J Wade Harper,et al.  Elevated Skp2 protein expression in human prostate cancer: association with loss of the cyclin-dependent kinase inhibitor p27 and PTEN and with reduced recurrence-free survival. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[17]  Shigeyoshi Itohara,et al.  Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis , 2000, Nature Cell Biology.

[18]  M. Kitagawa,et al.  Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication , 2000, The EMBO journal.

[19]  E. Benveniste,et al.  The Transcription Factors Sp1, Sp3, and AP-2 Are Required for Constitutive Matrix Metalloproteinase-2 Gene Expression in Astroglioma Cells* , 1999, The Journal of Biological Chemistry.

[20]  R. Fridman,et al.  Epidermal growth factor and amphiregulin up‐regulate matrix metalloproteinase‐9 (MMP‐9) in human breast cancer cells , 1997, International journal of cancer.